Vaccine

Article	Citations
Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?	782
Evidence for antibody as a protective correlate for COVID-19 vaccines	719
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic	465
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey	453
Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England	378
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong	349
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples	341
Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional surv	312
Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey	248
mRNA vaccines manufacturing: Challenges and bottlenecks	211
Human monkeypox – After 40 years, an unintended consequence of smallpox eradication	200
Myocarditis following COVID-19 mRNA vaccination	198
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge	185
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine	179
Vaccine hesitancy and perceived behavioral control: A meta-analysis	170
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data	162
The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States	140
Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data	137
Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis	135
Individual preferences for COVID-19 vaccination in China	134
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia	132
Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis	132
The disease burden of influenza beyond respiratory illness	127
COVID-19 vaccine intentions in the United States, a social-ecological framework	127
Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine	117

Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study	117
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018	114
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)	112
Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US	111
Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions	110
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial	110
Prenatal maternal COVID-19 vaccination and pregnancy outcomes	109
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization	106
The demand for a COVID-19 vaccine in Ecuador	104
Towards a population-based threshold of protection for COVID-19 vaccines	104
Contingent assessment of the COVID-19 vaccine	101
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia	100
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization	99
Arboviruses: A global public health threat	99
Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines	97
Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response	97
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis	94
Preferences for a COVID-19 vaccine in Australia	93
Timing of COVID-19 vaccine approval and endorsement by public figures	93
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches	84
Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-indu	82
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic	80
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults	79
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization	78
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia	77
Christian nationalism and COVID-19 vaccine hesitancy and uptake	75
Influenza immunization and COVID-19	74
COVID-19 vaccine – Long term immune decline and breakthrough infections	74
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models	72
Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis	72
Vaccination against coronaviruses in domestic animals	70
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use	69
Parents’ hesitancy towards vaccination in Indonesia: A cross-sectional study in Indonesia	69
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis	68
The need for inclusion of pregnant women in COVID-19 vaccine trials	68
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis	66
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis	66
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs	65
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey	65
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization	65
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates	64
Canadian parents’ perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey	63
Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies	63
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data	62
Global production capacity of seasonal and pandemic influenza vaccines in 2019	62
Prophylactic HPV vaccination after conization: A systematic review and meta-analysis	62
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement	61
Understanding immunosenescence and its impact on vaccination of older adults	61
Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake	59
When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil	59

Extraordinary diseases require extraordinary solutions	59
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines	58
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada	58
Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy	58
Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access	58
Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality	57
The determinants of vaccine hesitancy in China: A cross-sectional study following the Changchun Changsheng vaccine incident	57
Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates	57
Parental plans to vaccinate children for COVID-19 in New York city	57
Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis	56
Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK	55
Barriers and drivers to adult vaccination among family physicians – Insights for tailoring the immunization program in Germany	55
Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research	55
Optimal planning of the COVID-19 vaccine supply chain	54
Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment	53
Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries	53
Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines, an infodemiology study	53
Immunization stress-related response – Redefining immunization anxiety-related reaction as an adverse event following immunization	52
Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes	52
COVID-19 vaccination rates vary by community vulnerability: A county-level analysis	51
Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general	50
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment	50
Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a Wo	50
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety	49
Global vaccine action plan lessons learned I: Recommendations for the next decade	49
Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply	49
Low COVID-19 vaccine hesitancy in Brazil	49
Improving the quality and use of immunization and surveillance data: Summary report of the Working Group of the Strategic Advisory Group of Experts on Immunization	49
Willingness to pay and financing preferences for COVID-19 vaccination in China	48
The relationship between parental source of information and knowledge about measles / measles vaccine and vaccine hesitancy	48
Importance of COVID-19 vaccine efficacy in older age groups	48
Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications	48
Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students	47
Global assessment of national mandatory vaccination policies and consequences of non-compliance	47
Planning for COVID-19 vaccines safety surveillance	47
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults	46
Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse	46
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action	45
Healthcare Workers’ (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis	45
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS	45
Influenza vaccination rate and its association with chronic diseases in China: Results of a national cross-sectional study	45
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies	44
Persuasive messaging to increase COVID-19 vaccine uptake intentions	44
Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore	44
Interpreting vaccine efficacy trial results for infection and transmission	44
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019	43
Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020	43
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice	43
Immunoinformatics and molecular docking studies reveal a novel Multi-Epitope peptide vaccine against pneumonia infection	42
Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults	42
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries	42
Ethics of a partially effective dengue vaccine: Lessons from the Philippines	42
Prospective associations of regional social media messages with attitudes and actual vaccination: A big data and survey study of the influenza vaccine in the United States	42
Missed childhood immunizations during the COVID-19 pandemic in Brazil: Analyses of routine statistics and of a national household survey	41
A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China	41
Using Facebook to increase coverage of HPV vaccination among Danish girls: An assessment of a Danish social media campaign	41
Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data	41
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group	41
Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys	40
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection	40
“Vaccines for pregnant women…?! Absurd” – Mapping maternal vaccination discourse and stance on social media over six months	40
A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates	40
Strategic health communication on social media: Insights from a Danish social media campaign to address HPV vaccination hesitancy	40
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational stu	40
Influence of rapid COVID-19 vaccine development on vaccine hesitancy	40
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18–49 years of age	40
An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design	39
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial	39
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study	39
Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States	39
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines	39
Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States	39
Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates	39
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates	39
Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development	39
Beliefs towards vaccination and trust in the scientific community in Italy	39
Incidence of community-acquired pneumonia in urban China: A national population-based study	39
Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies	39
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents	39
Childhood vaccination coverage and equity impact in Ethiopia by socioeconomic, geographic, maternal, and child characteristics	39

Acceptability of an inactivated influenza vaccine delivered by microneedle patch: Results from a phase I clinical trial of safety, reactogenicity, and immunogenicity	39
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial	38
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and olde	38
Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK	38
Covid-19 vaccine immunogenicity in people living with HIV-1	38
Parental vaccine hesitancy and its association with adolescent HPV vaccination	38
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021	37
Henoch-Schönlein purpura presenting post COVID-19 vaccination	37
Bacillus Calmette–Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality	37
Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis	37
Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: A cross-sectional study in Indonesia	37
The effect of Bacillus Calmette–Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic	37
Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships	37
The Health Belief Model in predicting healthcare workers' intention for influenza vaccine uptake in Jordan	36
Pneumococcal vaccination in older adults: An initial analysis of social determinants of health and vaccine uptake	36
Underserved population acceptance of combination influenza-COVID-19 booster vaccines	36
Awareness and knowledge of HPV and HPV vaccination among adults ages 27–45 years	36
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of ag	35
COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout	35
The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism	35
Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis	35
The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis	35
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021	34
The missing season: The impacts of the COVID-19 pandemic on influenza	34
Do parasite infections interfere with immunisation? A review and meta-analysis	34
Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic	34
The development of COVID-19 vaccines in the United States: Why and how so fast?	34
Impact of the Sinopharm’s BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UA	34
A framework for the systematic consideration of ethics, equity, feasibility, and acceptability in vaccine program recommendations	34
Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework	34
Myocarditis following COVID-19 vaccination – A case series	34
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations	34
Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines	33
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review	33
Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study	33
COVID-19 vaccine hesitancy among persons living in homeless shelters in France	33
Acceptance of a COVID-19 vaccine: A multifactorial consideration	33
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis	33
Type I pili, CsuA/B and FimA induce a protective immune response against Acinetobacter baumannii	32
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analys	32
India’s cost-effective COVID-19 vaccine development initiatives	32
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial	32
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform	32
A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci	32
The sources and correlates of exposure to vaccine-related (mis)information online	32
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination	32
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection	32
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future	32
Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race	31
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon	31
Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US)	31
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?	31
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents	31
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG	31
Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials	31
The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies	31
UAE efforts in promoting COVID-19 vaccination and building vaccine confidence	31
Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic	31
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies	31
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice	31
Chlamydia trachomatis: Cell biology, immunology and vaccination	31
Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers	31
A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017–18 influe	31
Factors limiting data quality in the expanded programme on immunization in low and middle-income countries: A scoping review	31
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination	30
Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes	30
COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study	30
The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome	30
Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study	30
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial	30
COVID-19 related immunization disruptions in Rajasthan, India: A retrospective observational study	30
The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies	30
Looking ahead: Caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model	30
Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada	30
Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162	29
The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers’ recommendation of influenza vaccine in pregnancy	29
Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination	29
Influenza vaccination in the time of COVID-19: A national U.S. survey of adults	29
A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines	29
COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?	29
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July–December 2020)	28
Parental attitudes towards mandatory vaccination; a systematic review	28
Continuity of routine immunization programs in Canada during the COVID-19 pandemic	28
DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial	28
Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities	28
Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials	28
Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand	28
“Any idea how fast ‘It’s just a mask!’ can turn into ‘It’s just a vaccine!’”: From mask mandates to vaccine mandates during the COVID-19 pandemic	28
Chinese social media suggest decreased vaccine acceptance in China: An observational study on Weibo following the 2018 Changchun Changsheng vaccine incident	28
Feasibility assessment of measles and rubella eradication	27
Could live attenuated vaccines better control COVID-19?	27
Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic	27
Disparities in COVID-19 vaccine uptake among health care workers	27
Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine	27
Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada	27